The WEEE and RoHS Directives are currently undergoing a "recast" in the European Union, and both will have significant implications for the medical device industry. This is particularly true in the case of the RoHS Directive, where medical devices will almost certainly be included for the first time. As a result, there will be important new considerations for component procurement, design, manufacturing and support. Manufacturers need to understand that obtaining exemptions is likely to become more complex as well.
In this conference, our speaker explains how the changes to the WEEE Directive as proposed will introduce recovery and recycling targets, and may make trans-boundary shipments of articles/assemblies for repair, investigation or refurbishment more complicated.
WEEE and RoHS Revisions: Implications for Medical Device Manufacturers is being presented by Andrew Vaughan, Environmental Systems Specialist, with Donawa Lifescience Consulting and airs on Thursday, February 4, 2010. For more details or to register, please visit our site at www.fxconferences.com
